ABSTRACTThe purpose of this study is to report on five speech production protocols collected as part of the Food and Drug Administration's Clinical Trials for the Nucleus multichannel cochlear implant. Sixty-one children, ranging in age from 2.4 years to 17.8 years, participated. Speech measures included nonsegmental and segmental portions of thePhonetic Level Speech Evaluation, thePhonologic Level Speech Evaluation, speech intelligibility, and an experimental condition examining speech produced with the device turned on versus off. Seventy-seven percent of the children improved on at least one-third of the speech production measures. Significant improvements in the ability to imitate prosodic characteristics were observed for 31.1 percent of the children. Improvements in the ability to imitate speech sounds were found for 66.7 percent of the children. Examination of phonologic skills acquired during spontaneous speaking improved or 55.6 percent of the children. Speech intelligibility improved in 62.9 percent of the children after implantation. More centralized second format frequencies were observed in vowels produced with the speech processor turned off, as opposed to on, in all 13 of the children tested on this protocol. Data from this study suggest a multichannel cochlear implant may assist many children in developing better speech.
展开▼
